Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.84% |
| 4 | Consumer Discretionary | 9.23% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LITS
2601
Lite Strategy Inc
LITS
$31.4M
| $845K | ﹤0.01% |
31,075
+7,140
| +30% | +$200K |
|
|
GENE
2602
DELISTED
Genetic Technologies Ltd.
GENE
| $843K | ﹤0.01% |
20,174
+4,455
| +28% | +$205K |
|
2603
Weyco Group
WEYS
$446M
| $839K | ﹤0.01% |
30,200
-1,300
| -4% | -$35.7K |
|
|
KWY
2604
Kingsway Corp
KWY
$283M
| $836K | ﹤0.01% |
155,770
+17,071
| +12% | +$82.8K |
|
2605
American Coastal Insurance
ACIC
$465M
| $835K | ﹤0.01% |
51,000
-27,500
| -35% | -$468K |
|
2606
AMCON Distributing
DIT
$66.4M
| $833K | ﹤0.01% |
13,950
+150
| +1% | +$8.52K |
|
|
CBIO
2607
Crescent Biopharma
CBIO
$610M
| $833K | ﹤0.01% |
1,146
+454
| +66% | +$313K |
|
|
CUK
2608
DELISTED
Carnival PLC
CUK
| $829K | ﹤0.01% |
18,500
-84,700
| -82% | -$4.29M |
|
|
BOXC
2609
DELISTED
Brookfield Can Office Properties
BOXC
| $828K | ﹤0.01% |
37,400
+800
| +2% | +$17.7K |
|
2610
Verastem
VSTM
$604M
| $825K | ﹤0.01% |
52,908
+14,788
| +39% | +$260K |
|
2611
KNOT Offshore Partners
KNOP
$362M
| $821K | ﹤0.01% |
+44,254
| New | +$801K |
|
2612
LXP Industrial Trust
LXP
$3.58B
| $821K | ﹤0.01% |
16,236
-462,790
| -97% | -$21.4M |
|
|
MPX
2613
DELISTED
Marine Products Corp
MPX
| $818K | ﹤0.01% |
96,700
+19,200
| +25% | +$158K |
|
|
AVNS
2614
DELISTED
Avanos Medical
AVNS
| $816K | ﹤0.01% |
+25,100
| New | +$769K |
|
2615
Destination XL Group
DXLG
$33M
| $813K | ﹤0.01% |
177,900
+10,500
| +6% | +$52.1K |
|
|
MZOR
2616
DELISTED
Mazor Robotics Ltd.
MZOR
| $806K | ﹤0.01% |
44,800
-35,500
| -44% | -$495K |
|
2617
Virco
VIRC
$95.5M
| $804K | ﹤0.01% |
184,900
+9,800
| +6% | +$35.4K |
|
|
SPNE
2618
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $804K | ﹤0.01% |
76,700
+60,300
| +368% | +$727K |
|
|
WPT
2619
DELISTED
World Point Terminals, LP
WPT
| $803K | ﹤0.01% |
+50,803
| New | +$765K |
|
|
CSW
2620
CSW Industrials
CSW
$5.65B
| $802K | ﹤0.01% |
+24,600
| New | +$803K |
|
|
VXRT
2621
DELISTED
Vaxart
VXRT
| $801K | ﹤0.01% |
51,982
+1,618
| +3% | +$26.9K |
|
2622
Southern Missouri Bancorp
SMBC
$850M
| $800K | ﹤0.01% |
+34,000
| New | +$820K |
|
2623
Live Oak Bancshares
LOB
$1.98B
| $797K | ﹤0.01% |
+56,500
| New | +$861K |
|
|
MITT
2624
TPG Mortgage Investment Trust
MITT
$213M
| $796K | ﹤0.01% |
18,367
-17,900
| -49% | -$737K |
|
2625
Wintrust Financial
WTFC
$11B
| $796K | ﹤0.01% |
15,600
-148,992
| -91% | -$7.46M |
|
Similar funds
Jim Simons's Q2 2016 Portfolio in Review
As of Q2 2016, Jim Simons held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Jim Simons withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Jim Simons opened a new position in Nike worth $280M.
- Jim Simons's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Jim Simons added most to CVS Health in Q2 2016, an estimated $363M increase.
- Jim Simons's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Jim Simons fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Jim Simons opened 423 new positions and closed 474 in Q2 2016.
- Jim Simons's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.